SCHEMBL10027970

SCHEMBL10027970

CCC(C)(C)C(=O)Nc1ccccc1OCOC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.50
▸ POLB P06746 2/20 0.50
▸ GAA P10253 1/20 0.48
▸ PDK1 Q15118 1/20 0.47
▸ PDK2 Q15119 1/20 0.47
▸ PDK3 Q15120 1/20 0.47
▸ PDK4 Q16654 1/20 0.47
▸ TSHR P16473 1/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ ATM Q13315 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ BRD4 O60885 1/20 0.43
▸ RIPK1 Q13546 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10027965 0.88 GAA (0.50) LMNAPOLBGAAPDK1PDK2
SCHEMBL10027971 0.81 LMNA (0.57) LMNAPOLBGAAPDK1PDK2
SCHEMBL10027963 0.77 LMNA (0.47) LMNAPOLBGAAPDK1PDK2
SCHEMBL825407 0.77 KMT2A (0.49) LMNAPOLBPDK1PDK2PDK3
SCHEMBL10027967 0.77 LMNA (0.49) LMNAPOLBGAAPDK1PDK2
SCHEMBL14026905 0.75 GAA (0.55) LMNAPOLBGAATSHRKMT2A
SCHEMBL10027968 0.75 KMT2A (0.77) LMNAPOLBGAATSHRKMT2A
SCHEMBL1866821 0.74 LMNA (0.50) LMNAGAATSHRKMT2ACYP2C19
SCHEMBL1871151 0.74 BRD4 (0.48) LMNAPOLBGAATSHRKMT2A
SCHEMBL10684049 0.74 PDK1 (0.59) LMNAPOLBPDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120021357-A1 POSITIVE-TYPE PHOTOSENSITIVE INSULATING RESIN COMPOSITION, AND PATTERN FORMING METHOD USING SAME NEC CORPORATION (JP) 2012-01-26 — — US disclosed
US-7939241-B2 (Meth)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2011-05-10 — — US disclosed
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method NEC CORPORATION (JP) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090068587-A1 (Meth) acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and patterning method MMAB, DNMT3A, MAT1A LMNA 4190/4885POLB 672/4885GAA 2810/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback